Skip to main content
Erschienen in: Surgery Today 5/2021

Open Access 02.10.2020 | Original Article

Determining the protective characteristics and risk factors for the development of anastomotic leakage after low anterior resection for rectal cancer

verfasst von: Nobuaki Suzuki, Shin Yoshida, Shinobu Tomochika, Yuki Nakagami, Yoshitaro Shindo, Yukio Tokumitsu, Michihisa Iida, Shigeru Takeda, Shoichi Hazama, Tomio Ueno, Hiroaki Nagano

Erschienen in: Surgery Today | Ausgabe 5/2021

Abstract

Purpose

Anastomotic leakage is one of the most serious postoperative complications associated with surgery for rectal cancer. The present study aimed to identify the protective characteristics and risk factors associated with anastomotic leakage after low anterior resection for rectal cancer.

Methods

This was a retrospective, single-center study conducted between January 2009 and December 2017 at our institution. In total, 136 rectal cancer patients who underwent low anterior resection were included in the study. We analyzed preoperative and intraoperative factors. In addition, the pelvic dimensions were measured using computed tomography in all cases.

Results

Among the 136 patients, anastomotic leakage occurred in 21 (15.4%), including 18 males and 3 females. The median body mass index was 21.1 kg/m2. The construction of a covering stoma was found to be a protective factor. In addition, the operation time (≥ 373 min), intraoperative blood loss (≥ 105 ml), and size of the pelvic inlet (≥ 113 mm) were identified as risk factors for anastomotic leakage.

Conclusion

The construction of a covering stoma was a possible protective factor. However, a longer operation time, higher intraoperative blood loss, and larger pelvic inlet dimensions were possible risk factors for developing anastomotic leakage after low anterior resection in patients with rectal cancer.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Advances in surgical procedures and adjuvant therapies have made sphincter-preserving surgery the standard operation for most patients with rectal cancer. Heald et al. introduced a new method called total mesorectal excision (TME) for the treatment of rectal cancer. TME as a novel surgical method is important for preventing injury to the fascia propria of the rectum. At present, this technique is considered the gold standard for managing rectal cancer surgery [13].
Anastomotic leakage (AL) is a postoperative complication that occurs in patients who undergo low anterior resection (LAR) for rectal cancer [46]. AL leads to several serious postoperative complications, including peritonitis, sepsis, need for re-operation or percutaneous intervention, prolonged hospitalization, increased medical costs [79], and a poor prognosis [10, 11]. The basic requirements for anastomotic healing are proper healthy bowel ends and tension-free anastomosis [12]. Previously reported risk factors for AL during surgery include the operation time, amount of intraoperative blood loss, and blood transfusion [13, 14]. Tsuruta et al. reported that a smaller ratio of the difference between the interspinous distance and diameter of the mesorectum to the depth of the lesser pelvic cavity (pelvic index) was associated with a higher risk of AL [15]. Similarly, a few studies have reported the detection of risk factors for AL using preoperative imaging findings [16, 17]. However, there is currently no consensus regarding the risk factors associated with AL.
The present study, therefore, explored the protective as well as risk factors for AL by analyzing preoperative and intraoperative features on preoperative reconstructed coronal and sagittal computed tomography (CT) images.

Methods

Study population

A total of 186 patients with rectal cancer who consecutively underwent surgery at the Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, between January 2009 and December 2017, were enrolled. Among those patients, 50 were excluded, because they underwent surgery using other methods (Miles’ operation, n = 16; Hartmann’s operation, n = 8; total pelvic extirpation, n = 3; transanal operation, n = 17; and others, n = 6). A total of 136 patients with primary rectal cancer were finally included in this study (Fig. 1). Preoperative chemotherapy or chemoradiotherapy was administered for complex cases, such as bulky tumors or tumors with extramural invasion [18]. Ten patients underwent preoperative chemotherapy, and two patients underwent chemoradiotherapy (Table 1).
Table 1
Patient characteristics
Variables
All (n = 136)
All (n = 136)
p value
AL: − (n = 115)
AL: + (n = 21)
AL: −/+
115/21 (84.6/15.4)
   
Sex: Female/Male
55/81 (40.4/59.6)
52/63 (45.2/54.8)
3/18 (14.3/85.7)
0.016
Age†
68.0 [60.8, 74.0]
68.0 [61.0, 74.0]
65.0 [59.0, 69.0]
0.134
BMI†
21.4 [19.5, 23.7]
21.5 [19.4, 23.9]
21.1 [20.7, 23.4]
0.964
Section: Ra/Rb
60/76 (44.1/55.9)
53/62 (46.1/53.9)
7/14 (33.3/66.7)
0.399
NLR†
2.4 [1.8, 3.4]
2.3 [1.8, 3.3]
2.9 [2.4, 3.4]
0.075
LMR†
5.1 [3.5, 6.3]
5.2 [3.6, 6.4]
4.9 [3.2, 5.7]
0.293
Alb†
4.2 [3.9, 4.5]
4.2 [3.9, 4.5]
4.1 [3.7, 4.4]
0.242
Stoma: −/+
84/52 (61.8/38.2)
68/47 (59.1/40.9)
16/5 (76.2/23.8)
0.217
Drain: −/+
72/64 (52.9/47.1)
60/55 (52.2/47.8)
12/9 (57.1/42.9)
0.856
Operation time (min)†
348.5 [298.8, 453.2]
339.0 [295.0, 436.0]
445.0 [369.0, 489.0]
0.037
Blood loss (ml)†
53.0 [20.0, 210.0]
50.0 [20.0, 175.0]
190.0 [50.0, 573.0]
0.014
Tumor size (mm)†
35.0 [22.0, 50.0]
33.0 [20.0, 50.0]
60.0 [40.0, 70.0]
< 0.001
Laparotomy: −/+
122/14 (89.7/10.3)
106/9 (92.2/7.8)
16/5 (76.2/23.8)
0.043
UICC-T factor
   
0.213
 T0
1 (0.7)
1 (0.9)
0 (0.0)
 
 Tis
2 (1.5)
2 (1.7)
0 (0.0)
 
 T1
33 (24.3)
31 (27.0)
2 (9.5)
 
 T2
36 (26.5)
32 (27.8)
4 (19.0)
 
 T3
60 (44.1)
46 (40.0)
14 (66.7)
 
 T4
4 (2.9)
3 (2.6)
1 (4.8)
 
UICC-stage
   
0.137
 0
1 (0.7)
1 (0.9)
0 (0.0)
 
 I
61 (44.9)
56 (48.7)
5 (23.8)
 
 II
16 (11.8)
12 (10.4)
4 (19.0)
 
 III
40 (29.4)
33 (28.7)
7 (33.3)
 
 IV
18 (13.2)
13 (11.3)
5 (23.8)
 
Neoadjuvant treatment*: −/+
124/12 (91.2/8.8)
104/11 (90.4/9.6)
20/1 (95.2/4.8)
0.691
Lateral pelvis (mm)†
141.0 [135.0, 146.0]
141.0 [136.0, 146.0]
142.0 [132.0, 144.0]
0.400
Sacrum (mm)†
123.0 [114.0, 133.2]
123.0 [114.0, 132.5]
130.0 [119.0, 142.0]
0.029
Pelvic inlet (mm)†
115.0 [105.0, 122.0]
114.0 [105.0, 121.5]
115.0 [109.0, 123.0]
0.545
Pelvic outlet (mm)†
89.0 [84.0, 96.2]
89.0 [84.0, 98.0]
91.0 [83.0, 94.0]
0.411
Values in parentheses are percentages; †, median [interquartile range]; *, Neoadjuvant treatment includes neoadjuvant chemotherapy/chemoradiotherapy
AL anastomotic leakage; BMI body mass index; NLR neutrophil–lymphocyte ratio; LMR lymphocyte-monocyte ratio; Alb serum albumin; Tis tumor in situ
We examined the following variables that represented protective and risk factors for AL: sex, age, body mass index (BMI), tumor location (upper rectum [Ra] or lower rectum [Rb]), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), serum albumin (Alb), UICC-T factor, UICC-stage, diverting stoma construction, use of an intraluminal drain, operating time, intraoperative blood loss, tumor size, and laparotomy. The clinical stage was classified preoperatively according to the UICC-TNM classification (8th edition) and confirmed by postoperative histopathological examination findings.
The study was conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments and the ethical guidelines for clinical studies. The study protocol was approved by the institutional review board of Yamaguchi University (H28-186).

Surgical technique

The standard surgical technique for most patients was laparoscopic low anterior resection, except for a few patients who underwent open midline laparotomy. Ligation and resection of the inferior mesenteric artery and vein were performed, followed by TME. Intersphincteric resection was carried out for very low rectal tumors. Bilateral lymph node dissection was performed in cases, where the main tumor location was lower than Rb and the invasion depth was deeper than T3 [19]. The double stapling technique (DST) or handsewn anastomosis type of neorectal reconstruction was performed. A temporary stoma was created at the surgeons’ discretion. A transanal drain was inserted in all patients in the latter half of the study period.

Measurements of the pelvis

A pelvic CT examination was performed in all patients as a part of the routine preoperative work-up for rectal surgery. Using reconstructed coronal and sagittal CT images, a few examiners who were blinded to the patients’ information evaluated the following dimensions of the pelvis: a = length of the lateral pelvis, b = length of the pelvic inlet, c = length of the pelvic outlet, and d = length of the sacrum (Fig. 2). We used these parameters in further analyses.

Definition of anastomotic leakage

AL was detected based on the following clinical signs: discharge of pus or stool from the abdominal drain, presence of peritonitis with a high fever, tachycardia, abdominal pain, tenderness, or severe inflammation. The presence of an abscess, fluid collection, or free air surrounding the anastomotic site was checked for using CT to assess the presence of AL if any leak was suspected. However, asymptomatic AL was difficult to consider, as we did not perform contrast enemas routinely.

Statistical analyses

The continuous and categorical variables were expressed as median values (with interquartile range [IQR]) and frequencies, respectively. For the comparisons of variables between the non-AL and AL groups, the Mann–Whitney U test was conducted for continuous variables, and the Chi squared test or Fisher’s exact test was used for categorical variables. A receiver operating characteristic (ROC) curve analysis using logistic regression was used to determine the cut-off values based on the point closest to (0, 1) criterion for each continuous variable. To identify the protective/risk factors for AL, logistic regression analyses were performed. Variables were included in Firth’s bias-reduced multiple logistic regression analysis with the stepwise Akaike’s Information Criterion (AIC) variable selection method when a p value < 0.20 was observed in the univariate analysis. The confidence intervals and p values for each factor were calculated by the Wald method.
All statistical analyses were performed using R language (R Core Team URL https://​www.​R-project.​org/​, Vienna, Austria). The logistic regression, ROC curve analysis, variable selection based on AIC, and Firth’s bias-reduced multiple logistic regression were conducted using stats::glm, pROC::cords [20], stats::glm, and logistf:logistf functions, respectively. A p value < 0.05 was considered statistically significant.

Results

Patient characteristics

Table 1 shows the characteristics of the patients in the study. In total, 136 patients underwent LAR with DST or handsewn anastomosis, including 81 (59.6%) males and 55 (40.4%) females. The median age was 68.0 years (IQR, 60.8–74.0 years) and their median. The median BMI was 21.4 kg/m2 (IQR, 19.5–23.7 kg/m2). Sixty patients (44.1%) and 76 patients (55.9%) had Ra and Rb cancer, respectively. Twenty-one patients (15.4%) developed AL, including 18 males and 3 females. The median BMI was 21.1 kg/m2 (IQR, 20.7–23.4 kg/m2); 7 of them (33.3%) had Ra cancer, and 14 (66.7%) had Rb cancer. We performed re-operation on 17 patients (81.0%). We constructed a covering stoma and performed intraabdominal lavage and drainage in 16 of those 17 patients. Four of the five patients with covering stomas were treated using drainage. However, we performed re-operation with intraabdominal lavage and drainage on the remaining patient. There were 4 patients (19.0%) with AL who did not need re-operation and were treated by drainage with an abdominal drain. The median post-surgery time until hospital discharge was 44 days (range 14–89 days). There were no deaths related to AL in this study. Among the 136 patients, 52 (38.2%) underwent construction of a covering stoma, and 14 (10.3%) underwent laparotomy. Five of those 14 patients developed AL.

AL with or without a diverting stoma

We stratified patients based on the construction of a stoma, with the results, as shown in Table 2. Among the patients without stomas (n = 84), sex (p = 0.006), operation time (p < 0.001), blood loss (p = 0.024), and tumor size (p = 0.005) were the factors that showed significant differences between the AL (−) (n = 68) and AL (+) (n = 16) patients. Furthermore, Ra cancer was more frequent in AL (−) patients, while Rb cancer was more frequent in AL (+) patients (p = 0.051). Among patients who underwent construction of a stoma (n = 52), there were significant differences in intraoperative blood loss (p = 0.033), tumor size (p = 0.027), laparotomy (p = 0.004), UICC-stage (p = 0.015), and sacrum factors (p = 0.044) between AL (-) (n = 47) and AL (+) patients (n = 5).
Table 2
Patient characteristics stratified by stoma construction
Variables
Stoma: − (n = 84)
p value
Stoma: + (n = 52)
p value
AL: − (n = 68)
AL: + (n = 16)
AL: − (n = 47)
AL: + (n = 5)
Sex: female/male
37/31 (54.4/45.6)
2/14 (12.5/87.5)
0.006
15/32 (31.9/68.1)
1/4 (20.0/80.0)
1
Age†
68.0 [59.0, 75.2]
65.5 [59.5, 69.2]
0.198
68.0 [63.0, 71.9]
65.0 [59.0, 68.0]
0.446
BMI†
21.1 [19.2, 22.9]
21.4 [20.7, 23.4]
0.396
22.5 [20.2, 25.5]
20.7 [18.4, 21.1]
0.352
Section: Ra/Rb
46/22 (67.6/32.4)
6/10 (37.5/62.5)
0.051
7/40 (14.9/85.1)
1/4 (20.0/80.0)
1
NLR†
2.4 [1.8, 3.6]
2.9 [2.4, 3.2]
0.257
2.3 [1.7, 3.0]
3.4 [2.6, 3.9]
0.210
LMR†
5.3 [3.6, 6.6]
4.9 [3.2, 5.5]
0.415
4.8 [3.7, 6.2]
4.9 [3.2, 5.7]
0.555
Alb†
4.3 [4.0, 4.5]
4.2 [3.7, 4.4]
0.382
4.2 [3.8, 4.4]
3.8 [3.7, 3.9]
0.297
Drain: −/+
36/32 (52.9/47.1)
7/9 (43.8/56.2)
0.701
24/23 (51.1/48.9)
5/0 (100.0/0.0)
0.059
Operation time (min)†
304.5 [273.8, 339.0]
414.5 [320.8, 468.2]
< 0.001
466.0 [398.5, 619.0]
445.0 [419.0, 489.0]
0.733
Blood loss (ml)†
30.0 [15.0, 60.0]
112.5 [41.2, 540.0]
0.024
160.0 [38.5, 230.0]
1100.0 [190.0, 2365.0]
0.033
Tumor size (mm)†
30.0 [20.0, 50.0]
55.0 [38.8, 66.2]
0.005
35.0 [25.0, 50.0]
70.0 [55.0, 80.0]
0.027
Laparotomy: −/+
61/7 (89.7/10.3)
14/2 (87.5/12.5)
0.679
45/2 (95.7/4.3)
2/3 (40.0/60.0)
0.004
UICC-T factor
  
0.373
  
0.338
 T0
0 (0.0)
0 (0.0)
 
1 (2.1)
0 (0.0)
 
 Tis
1 (1.5)
0 (0.0)
 
1 (2.1)
0 (0.0)
 
 T1
22 (32.4)
2 (12.5)
 
9 (19.1)
0 (0.0)
 
 T2
18 (26.5)
4 (25.0)
 
14 (29.8)
0 (0.0)
 
 T3
25 (36.8)
9 (56.2)
 
21 (44.7)
5 (100.0)
 
 T4
2 (2.9)
1 (6.2)
 
1 (2.1)
0 (0.0)
 
UICC-stage
  
0.400
  
0.015
 0
1 (1.5)
0 (0.0)
 
0 (0.0)
0 (0.0)
 
 I
35 (51.5)
5 (31.2)
 
21 (44.7)
0 (0.0)
 
 II
9 (13.2)
2 (12.5)
 
3 (6.4)
2 (40.0)
 
 III
18 (26.5)
6 (37.5)
 
15 (31.9)
1 (20.0)
 
 IV
5 (7.4)
3 (18.8)
 
8 (17.0)
2 (40.0)
 
Neoadjuvant treatment*: −/+
68/0 (100.0/0.0)
16/0 (100.0/0.0)
1
36/11 (76.6/23.4)
4/1 (80.0/20.0)
1
Lateral pelvis (mm)†
142.0 [137.0, 148.0]
138.5 [131.8, 144.8]
0.168
140.0 [134.0, 144.0]
142.0 [132.0, 144.0]
0.804
Sacrum (mm)†
122.5 [114.0, 129.2]
128.0 [118.8, 140.0]
0.131
123.0 [113.0, 137.0]
145.0 [130.0, 151.0]
0.044
Pelvic inlet (mm)†
113.0 [105.0, 119.2]
115.5 [107.2, 123.2]
0.412
115.0 [105.5, 122.5]
115.0 [114.0, 115.0]
0.828
Pelvic outlet (mm)†
90.0 [84.0, 99.0]
89.0 [82.8, 94.5]
0.408
88.0 [84.0, 97.5]
91.0 [86.0, 92.0]
0.963
Values in parentheses are percentages; †, median [interquartile range]; *, Neoadjuvant treatment includes neoadjuvant chemotherapy/chemoradiotherapy
AL anastomotic leakage, BMI body mass index, NLR neutrophil–lymphocyte ratio, LMR lymphocyte-monocyte ratio, Alb serum albumin, Tis tumor in situ

Univariate and multivariate analyses

Finally, we checked for an association between the construction of a stoma and AL. Table 3 shows the results of univariate and multivariate logistic regression analyses. Firth’s bias-reduced multiple logistic regression analyses with the stepwise AIC variable selection method identified the variables of age (≥ 67 years), Alb (≥ 4 g/dl), and stoma (+) as protective factors and sex (male), NLR (≥ 2.4), LMR (≥ 5.3), operation time (≥ 373 min), blood loss (≥ 105 ml), tumor size (≥ 41 mm), and pelvic inlet size (≥ 113 mm) as risk factors for AL. The area under the curve (AUC) was 0.95 (95% confidence interval [CI]: 0.91–0.99), suggesting that these identified factors were strongly associated with AL (Fig. 3). Among the pre- and intraoperative factors, the construction of a covering stoma (stoma + , odds ratio [OR] 0.05, 95% CI [21] 0.01–0.26) was found to be a strong protective factor, and the operation time (≥ 373 min, OR 9.83, 95% CI 1.98–48.86), intraoperative blood loss (≥ 105 ml, OR 5.05, 95% CI 1.05–24.23), and pelvic inlet diameter (≥ 113 mm, OR 5.07, 95% CI 1.13–22.66) were identified as strong risk factors for AL from the multivariate analysis.
Table 3
Results of a logistic regression analysis
Variables
Univariate analysis
Multivariate analysis†
OR
95% CI
p value
OR
95% CI
p value
Lower
Upper
Lower
Upper
Sex: Male
4.95
1.38
17.74
0.014
3.85
0.92
16.09
0.065
Age (years) ≥ 67
0.43
0.17
1.11
0.081
0.39
0.11
1.44
0.157
BMI ≥ 21
1.03
0.40
2.62
0.958
    
Section: Rb
1.71
0.64
4.55
0.283
    
NLR ≥ 2.4
4.80
1.52
15.15
0.007
3.42
0.73
16.00
0.119
LMR ≥ 5.3
0.53
0.20
1.40
0.199
2.90
0.62
13.58
0.175
Alb ≥ 4
0.39
0.15
1.01
0.051
0.29
0.07
1.16
0.081
Stoma: +
0.45
0.16
1.32
0.146
0.05
0.01
0.26
< 0.001
Drain: +
0.82
0.32
2.09
0.675
    
Operation time (min) ≥ 373
4.51
1.63
12.52
0.004
9.83
1.98
48.86
0.005
Blood loss (ml) ≥ 105
3.75
1.40
10.04
0.009
5.05
1.05
24.23
0.043
Tumor size (mm) ≥ 41
5.49
1.97
15.30
0.001
2.66
0.70
10.05
0.149
Laparotomy: +
3.68
1.09
12.38
0.035
    
UICC-T: (T3, T4) vs. (T0, Tis, T1, T2)
3.37
1.22
9.30
0.019
    
UICC-stage: (III, IV) vs. (0, I, II)
2.00
0.78
5.13
0.149
    
Lateral pelvis (mm) ≥ 142
1.24
0.49
3.15
0.648
    
Sacrum (mm) ≥ 129
2.81
1.09
7.26
0.033
    
Pelvic inlet (mm) ≥ 113
2.06
0.75
5.70
0.162
5.07
1.13
22.66
0.034
Pelvic outlet (mm) ≥ 91
1.65
0.65
4.20
0.293
    
†Variables were included in the Firth’s bias-reduced multiple logistic regression analysis with the stepwise AIC variable selection method when a p-value < 0.20 was observed in the univariate analysis
AIC Akaike’s Information Criterion, BMI body mass index, NLR neutrophil–lymphocyte ratio, LMR lymphocyte-monocyte ratio, Alb serum albumin, Tis tumor in situ, OR odds ratio, CI confidence interval

Discussion

In our study, the overall rate of AL occurrence was 15.4% (21/136). In patients with stomal construction, the rate of AL occurrence was 9.6% (5/52), and in those without a stoma, the AL rate was 19.0% (16/84). In our institute, the rate of AL was nearly 10% in patients with covering stomas, which was markedly higher than that recorded in the Japanese database [22]. Regarding the consecutive patients that we evaluated in this study, there were 14 patients with laparotomy who developed AL significantly more frequently than laparoscopic procedure (p = 0.043), and among them, 3 of the 5 patients with covering stomas had AL. Regarding cases without laparotomy, there were 16 patients out of 122 (13.1%) and 2 out of 47 (4.3%) who had AL among all patients and those with stomas, respectively.
As we performed laparoscopic surgery in most cases, there were some cases with bulky tumors, and resection of these large lesions was difficult. There might have been some bias in the decision to construct a stoma, since it depended on the intraoperative findings. In other words, surgeons constructed a stoma in serious cases, so some reports found no relationship between AL and stoma construction [23, 24]. Our comparisons (Table 1) and a univariate analysis (Table 3) of the association between AL and stoma construction did not show any statistical significance. However, the multivariate logistic regression analysis showed that the construction of a covering stoma was a strong protective factor when other variables were held constant.
Figure 3 suggests that the AUC was 0.95 (95% CI 0.91–0.99), and the analyzed factors (i.e., sex, age, NLR, LMR, Alb, stoma, operation time, blood loss, tumor size, and pelvic inlet) were strongly associated with AL. A further analysis showed that the operation time (≥ 373 min), intraoperative blood loss (≥ 105 min), and pelvic inlet diameter (≥ 113 mm) were strong risk factors for AL (Table 3). Several risk factors were reported based on preoperative and intraoperative findings. A few studies identified risk factors for AL by measuring the patients’ pelvic dimensions using preoperative imaging examinations. According to those studies, the preoperative and intraoperative risk factors included the sex, operation time, and amount of intraoperative blood loss [13, 14].
Several studies have concluded that male sex is a risk factor for AL [24, 25]. Similarly, the findings of our analysis also indicated that males were at a significant risk of developing AL. Furthermore, the operation time and intraoperative blood loss were also reported as major risk factors for AL in many studies [13, 26]. Our analysis provided results that were comparable to these previous findings. The pelvic index was also reported as a risk factor in a previous study [15]. Tsuruta et al. reported that a smaller ratio of the mesorectum to the depth of the cavity of the lesser pelvis was associated with an increased risk of AL. We also observed that a larger pelvic inlet size (≥ 113 mm) was a risk factor when other variables were held constant. From our analysis considering other clinical confounding factors, we did not detect any confounders. The univariate analysis might have been affected by other confounding factors. However, the multivariate analysis reduced these possible effects by other confounding factors. Therefore, regarding the pelvic index, the significant risk factors differed between the univariate and multivariate analyses. A longer sacrum and pelvic inlet were significant risk factors for AL in univariate and multivariate analyses, respectively (Table 3).
Initially, we measured several pelvic dimensions (short lengths of the lateral pelvis, anteroposterior diameter, and sacrum) under the hypothesis that males, with their narrow pelvis, might have a higher risk of AL than females. However, our analysis showed that a longer pelvic inlet was a significant risk factor for AL. This result may be explained by the presence of a deeper pelvis making it difficult to perform the operation. In other words, surgeons considered that the narrow pelvis during the operation was due not only to the skeletal structure but also the soft tissue, such as the muscles, intestinal size, and amount of mesenteric adipose tissue.
This study is limited by its nature as a retrospective record review performed at a single institution. In the future, our findings should be confirmed in more cases.

Conclusion

In conclusion, the results obtained after analyzing the data of 136 patients with rectal cancer suggested that the construction of a covering stoma was a possible protective factor. The results further indicated that a longer operation time, higher intraoperative blood loss, and larger pelvic inlet dimensions were possible risk factors for AL after low anterior resection in patients with rectal cancer. Further prospective studies may help clarify the pertinent factors predicting postoperative morbidity in patients with rectal cancer.

Acknowledgements

The authors thank Masao Nakajima MD, PhD, Yuta Kimura MD, Kou Kanesada MD, and the members of the Department of Gastroenterological, Breast and Endocrine Surgery at Yamaguchi University Graduate School of Medicine for their participation in this study. We would also like to thank Editage (www.​editage.​com) for the English language editing.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

This study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki Ethical and its later amendments. The study protocol and legal and social implications were approved by the Ethics Committee of Yamaguchi University Hospital (H28-186).
All study participants provided written informed consent prior to their inclusion in the study.
All of the authors were involved in final approval.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery–the clue to pelvic recurrence? Br J Surg. 1982;69:613–6.CrossRef Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery–the clue to pelvic recurrence? Br J Surg. 1982;69:613–6.CrossRef
2.
Zurück zum Zitat Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998;133:894–9.CrossRef Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998;133:894–9.CrossRef
3.
Zurück zum Zitat Matsuda T, Yamashita K, Hasegawa H, Oshikiri T, Hosono M, Higashino N, et al. Recent updates in the surgical treatment of colorectal cancer. Ann Gastroenterol Surg. 2018;2:129–36.CrossRef Matsuda T, Yamashita K, Hasegawa H, Oshikiri T, Hosono M, Higashino N, et al. Recent updates in the surgical treatment of colorectal cancer. Ann Gastroenterol Surg. 2018;2:129–36.CrossRef
4.
Zurück zum Zitat van der Pas MH, Haglind E, Cuesta MA, Furst A, Lacy AM, Hop WC, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14:210–8.CrossRef van der Pas MH, Haglind E, Cuesta MA, Furst A, Lacy AM, Hop WC, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14:210–8.CrossRef
5.
Zurück zum Zitat Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11:637–45.CrossRef Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11:637–45.CrossRef
6.
Zurück zum Zitat Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365:1718–26.CrossRef Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365:1718–26.CrossRef
7.
Zurück zum Zitat Boyce SA, Harris C, Stevenson A, Lumley J, Clark D. Management of low colorectal anastomotic leakage in the laparoscopic era: more than a decade of experience. Dis Colon Rectum. 2017;60:807–14.CrossRef Boyce SA, Harris C, Stevenson A, Lumley J, Clark D. Management of low colorectal anastomotic leakage in the laparoscopic era: more than a decade of experience. Dis Colon Rectum. 2017;60:807–14.CrossRef
8.
Zurück zum Zitat Ihnat P, Gunkova P, Peteja M, Vavra P, Pelikan A, Zonca P. Diverting ileostomy in laparoscopic rectal cancer surgery: high price of protection. Surg Endosc. 2016;30:4809–16.CrossRef Ihnat P, Gunkova P, Peteja M, Vavra P, Pelikan A, Zonca P. Diverting ileostomy in laparoscopic rectal cancer surgery: high price of protection. Surg Endosc. 2016;30:4809–16.CrossRef
9.
Zurück zum Zitat Hain E, Maggiori L, Manceau G, Zappa M. Prost a la Denise J, Panis Y: persistent asymptomatic anastomotic leakage after laparoscopic sphincter-saving surgery for rectal cancer: can diverting stoma be reversed safely at 6 months? Dis Colon Rectum. 2016;59:369–76.CrossRef Hain E, Maggiori L, Manceau G, Zappa M. Prost a la Denise J, Panis Y: persistent asymptomatic anastomotic leakage after laparoscopic sphincter-saving surgery for rectal cancer: can diverting stoma be reversed safely at 6 months? Dis Colon Rectum. 2016;59:369–76.CrossRef
10.
Zurück zum Zitat Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg. 2011;253:890–9.CrossRef Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg. 2011;253:890–9.CrossRef
11.
Zurück zum Zitat Bell SW, Walker KG, Rickard MJ, Sinclair G, Dent OF, Chapuis PH, et al. Anastomotic leakage after curative anterior resection results in a higher prevalence of local recurrence. Br J Surg. 2003;90:1261–6.CrossRef Bell SW, Walker KG, Rickard MJ, Sinclair G, Dent OF, Chapuis PH, et al. Anastomotic leakage after curative anterior resection results in a higher prevalence of local recurrence. Br J Surg. 2003;90:1261–6.CrossRef
12.
Zurück zum Zitat Braunschmid T, Hartig N, Baumann L, Dauser B, Herbst F. Influence of multiple stapler firings used for rectal division on colorectal anastomotic leak rate. Surg Endosc. 2017;31:5318–26.CrossRef Braunschmid T, Hartig N, Baumann L, Dauser B, Herbst F. Influence of multiple stapler firings used for rectal division on colorectal anastomotic leak rate. Surg Endosc. 2017;31:5318–26.CrossRef
13.
Zurück zum Zitat Konishi T, Watanabe T, Kishimoto J, Nagawa H. Risk factors for anastomotic leakage after surgery for colorectal cancer: results of prospective surveillance. J Am Coll Surg. 2006;202:439–44.CrossRef Konishi T, Watanabe T, Kishimoto J, Nagawa H. Risk factors for anastomotic leakage after surgery for colorectal cancer: results of prospective surveillance. J Am Coll Surg. 2006;202:439–44.CrossRef
14.
Zurück zum Zitat Makela JT, Kiviniemi H, Laitinen S. Risk factors for anastomotic leakage after left-sided colorectal resection with rectal anastomosis. Dis Colon Rectum. 2003;46:653–60.CrossRef Makela JT, Kiviniemi H, Laitinen S. Risk factors for anastomotic leakage after left-sided colorectal resection with rectal anastomosis. Dis Colon Rectum. 2003;46:653–60.CrossRef
15.
Zurück zum Zitat Tsuruta A, Tashiro J, Ishii T, Oka Y, Suzuki A, Kondo H, et al. Prediction of anastomotic leakage after laparoscopic low anterior resection in male rectal cancer by pelvic measurement in magnetic resonance imaging. Surg Laparosc Endosc Percutan Tech. 2017;27:54–9.CrossRef Tsuruta A, Tashiro J, Ishii T, Oka Y, Suzuki A, Kondo H, et al. Prediction of anastomotic leakage after laparoscopic low anterior resection in male rectal cancer by pelvic measurement in magnetic resonance imaging. Surg Laparosc Endosc Percutan Tech. 2017;27:54–9.CrossRef
16.
Zurück zum Zitat Watanabe T, Miyata H, Konno H, Kawai K, Ishihara S, Sunami E, et al. Prediction model for complications after low anterior resection based on data from 33,411 Japanese patients included in the National Clinical Database. Surgery. 2017;161:1597–608.CrossRef Watanabe T, Miyata H, Konno H, Kawai K, Ishihara S, Sunami E, et al. Prediction model for complications after low anterior resection based on data from 33,411 Japanese patients included in the National Clinical Database. Surgery. 2017;161:1597–608.CrossRef
17.
Zurück zum Zitat Zur Hausen G, Grone J, Kaufmann D, Niehues SM, Aschenbrenner K, Stroux A, et al. Influence of pelvic volume on surgical outcome after low anterior resection for rectal cancer. Int J Colorectal Dis. 2017;32:1125–35.CrossRef Zur Hausen G, Grone J, Kaufmann D, Niehues SM, Aschenbrenner K, Stroux A, et al. Influence of pelvic volume on surgical outcome after low anterior resection for rectal cancer. Int J Colorectal Dis. 2017;32:1125–35.CrossRef
18.
Zurück zum Zitat Yoo RN, Kim HJ. Total neoadjuvant therapy in locally advanced rectal cancer: role of systemic chemotherapy. Ann Gastroenterol Surg. 2019;3:356–67.CrossRef Yoo RN, Kim HJ. Total neoadjuvant therapy in locally advanced rectal cancer: role of systemic chemotherapy. Ann Gastroenterol Surg. 2019;3:356–67.CrossRef
19.
Zurück zum Zitat Sammour T, Chang GJ. Lateral pelvic lymph node dissection and radiation treatment for rectal cancer: mutually exclusive or mutually beneficial? Ann Gastroenterol Surg. 2018;2:348–50.CrossRef Sammour T, Chang GJ. Lateral pelvic lymph node dissection and radiation treatment for rectal cancer: mutually exclusive or mutually beneficial? Ann Gastroenterol Surg. 2018;2:348–50.CrossRef
20.
Zurück zum Zitat Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S + to analyze and compare ROC curves. BMC Bioinform. 2011;12:77.CrossRef Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S + to analyze and compare ROC curves. BMC Bioinform. 2011;12:77.CrossRef
21.
Zurück zum Zitat Sciuto A, Merola G, De Palma GD, Sodo M, Pirozzi F, Bracale UM, et al. Predictive factors for anastomotic leakage after laparoscopic colorectal surgery. World J Gastroenterol. 2018;24:2247–60.CrossRef Sciuto A, Merola G, De Palma GD, Sodo M, Pirozzi F, Bracale UM, et al. Predictive factors for anastomotic leakage after laparoscopic colorectal surgery. World J Gastroenterol. 2018;24:2247–60.CrossRef
22.
Zurück zum Zitat Matsubara N, Miyata H, Gotoh M, Tomita N, Baba H, Kimura W, et al. Mortality after common rectal surgery in Japan: a study on low anterior resection from a newly established nationwide large-scale clinical database. Dis Colon Rectum. 2014;57:1075–81.CrossRef Matsubara N, Miyata H, Gotoh M, Tomita N, Baba H, Kimura W, et al. Mortality after common rectal surgery in Japan: a study on low anterior resection from a newly established nationwide large-scale clinical database. Dis Colon Rectum. 2014;57:1075–81.CrossRef
23.
Zurück zum Zitat Shiomi A, Ito M, Maeda K, Kinugasa Y, Ota M, Yamaue H, et al. Effects of a diverting stoma on symptomatic anastomotic leakage after low anterior resection for rectal cancer: a propensity score matching analysis of 1,014 consecutive patients. J Am Coll Surg. 2015;220:186–94.CrossRef Shiomi A, Ito M, Maeda K, Kinugasa Y, Ota M, Yamaue H, et al. Effects of a diverting stoma on symptomatic anastomotic leakage after low anterior resection for rectal cancer: a propensity score matching analysis of 1,014 consecutive patients. J Am Coll Surg. 2015;220:186–94.CrossRef
24.
Zurück zum Zitat Hamabe A, Ito M, Nishigori H, Nishizawa Y, Sasaki T. Preventive effect of diverting stoma on anastomotic leakage after laparoscopic low anterior resection with double stapling technique reconstruction applied based on risk stratification. Asian J Endosc Surg. 2018;11:220–6.CrossRef Hamabe A, Ito M, Nishigori H, Nishizawa Y, Sasaki T. Preventive effect of diverting stoma on anastomotic leakage after laparoscopic low anterior resection with double stapling technique reconstruction applied based on risk stratification. Asian J Endosc Surg. 2018;11:220–6.CrossRef
25.
Zurück zum Zitat Shinji S, Ueda Y, Yamada T, Koizumi M, Yokoyama Y, Takahashi G, et al. Male sex and history of ischemic heart disease are major risk factors for anastomotic leakage after laparoscopic anterior resection in patients with rectal cancer. BMC Gastroenterol. 2018;18:117.CrossRef Shinji S, Ueda Y, Yamada T, Koizumi M, Yokoyama Y, Takahashi G, et al. Male sex and history of ischemic heart disease are major risk factors for anastomotic leakage after laparoscopic anterior resection in patients with rectal cancer. BMC Gastroenterol. 2018;18:117.CrossRef
26.
Zurück zum Zitat Fukada M, Matsuhashi N, Takahashi T, Imai H, Tanaka Y, Yamaguchi K, et al. Risk and early predictive factors of anastomotic leakage in laparoscopic low anterior resection for rectal cancer. World J Surg Oncol. 2019;17:178.CrossRef Fukada M, Matsuhashi N, Takahashi T, Imai H, Tanaka Y, Yamaguchi K, et al. Risk and early predictive factors of anastomotic leakage in laparoscopic low anterior resection for rectal cancer. World J Surg Oncol. 2019;17:178.CrossRef
Metadaten
Titel
Determining the protective characteristics and risk factors for the development of anastomotic leakage after low anterior resection for rectal cancer
verfasst von
Nobuaki Suzuki
Shin Yoshida
Shinobu Tomochika
Yuki Nakagami
Yoshitaro Shindo
Yukio Tokumitsu
Michihisa Iida
Shigeru Takeda
Shoichi Hazama
Tomio Ueno
Hiroaki Nagano
Publikationsdatum
02.10.2020
Verlag
Springer Singapore
Erschienen in
Surgery Today / Ausgabe 5/2021
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-020-02133-0

Weitere Artikel der Ausgabe 5/2021

Surgery Today 5/2021 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.